1. Home
  2. VERI vs ELTX Comparison

VERI vs ELTX Comparison

Compare VERI & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERI
  • ELTX
  • Stock Information
  • Founded
  • VERI 2014
  • ELTX 2011
  • Country
  • VERI United States
  • ELTX United States
  • Employees
  • VERI N/A
  • ELTX N/A
  • Industry
  • VERI EDP Services
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VERI Technology
  • ELTX Health Care
  • Exchange
  • VERI Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • VERI 124.0M
  • ELTX 121.7M
  • IPO Year
  • VERI 2017
  • ELTX N/A
  • Fundamental
  • Price
  • VERI $2.33
  • ELTX $6.30
  • Analyst Decision
  • VERI Strong Buy
  • ELTX Strong Buy
  • Analyst Count
  • VERI 2
  • ELTX 3
  • Target Price
  • VERI $5.25
  • ELTX $9.50
  • AVG Volume (30 Days)
  • VERI 398.0K
  • ELTX 36.3K
  • Earning Date
  • VERI 03-13-2025
  • ELTX 03-31-2025
  • Dividend Yield
  • VERI N/A
  • ELTX N/A
  • EPS Growth
  • VERI N/A
  • ELTX N/A
  • EPS
  • VERI N/A
  • ELTX N/A
  • Revenue
  • VERI $92,637,000.00
  • ELTX N/A
  • Revenue This Year
  • VERI $23.41
  • ELTX N/A
  • Revenue Next Year
  • VERI $26.79
  • ELTX N/A
  • P/E Ratio
  • VERI N/A
  • ELTX N/A
  • Revenue Growth
  • VERI N/A
  • ELTX N/A
  • 52 Week Low
  • VERI $2.03
  • ELTX $3.34
  • 52 Week High
  • VERI $7.76
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • VERI 39.23
  • ELTX 31.74
  • Support Level
  • VERI $2.60
  • ELTX $7.54
  • Resistance Level
  • VERI $2.84
  • ELTX $8.13
  • Average True Range (ATR)
  • VERI 0.19
  • ELTX 0.46
  • MACD
  • VERI 0.00
  • ELTX -0.13
  • Stochastic Oscillator
  • VERI 9.02
  • ELTX 1.61

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel and India.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: